Quick Answer
BioXcel Therapeutics, Inc. reported Shares Outstanding of 22.33 million shares for fiscal year 2025.
BioXcel Therapeutics, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 22.33M | +619.8% |
| 2024 | 3.10M | +65.8% |
| 2023 | 1.87M | -93.4% |
| 2022 | 28.15M | +0.6% |
| 2021 | 27.98M | +14.6% |
| 2020 | 24.42M | +35.0% |
| 2019 | 18.09M | +15.5% |
| 2018 | 15.66M | +58.1% |
| 2017 | 9.91M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 20.00M | -52.9% | +202.1% |
| June 30, 2025 | 6.62M | -83.6% | +21.1% |
| March 31, 2025 | 5.47M | -83.7% | +76.3% |
| December 31, 2024 | 3.10M | -89.6% | -92.7% |
| September 30, 2024 | 42.46M | +45.1% | +5.1% |
| June 30, 2024 | 40.38M | +38.0% | +20.1% |
| March 31, 2024 | 33.63M | +15.6% | +12.4% |
| December 31, 2023 | 29.93M | +6.3% | +2.2% |
- BioXcel Therapeutics, Inc. showed an increase of +619.8% in Shares Outstanding compared to the prior fiscal year.
- Over the 2017–2025 period, BioXcel Therapeutics, Inc.’s shares outstanding has grown by 125.4% (from 9.91 million shares to 22.33 million shares).
- The most recent figure is from BioXcel Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: